Next Phase Pilot Study Jackson Center, PA December 2, 2024 – Halberd Corporation (OTC-PINK: "HALB”) previously reported results of a recently concluded initial 10-person Pilot Study of volunteer veterans suffering from PTSD and possible suicidal ideation. The results of that study can be found here. Based on the encouraging results of that initial pilot study, ...
Ten Military Veteran Volunteers Participated in the Pilot Study Enabled by Athena GTX Health Monitoring System Jackson Center, PA October 1, 2024 – Halberd Corporation (OTC-PINK: "HALB”) released the results of the recently completed WatchDawg® Pilot Study. Ten (10) military veteran participated in the study where they received pharmaceuticals (LDX) and nutraceuticals, along with 24/7 ...
Breaking News: Development Just In! Contributing Funding and a Significant Additional Tool to Combat PTSD and TBI Jackson Center, PA September 11, 2024 – Halberd Corporation (OTC-PINK: "HALB”), in coordination with Athena Telemedicine Partners (ATP), and Athena GTX, Inc., is pleased to announce a substantial contract award commitment. Defense Atomics Corporation agreed to engage with ...
Early Pilot Study Data from Veteran Volunteers is Compelling. Part B. Jackson Center, PA September 5, 2024 – Halberd Corporation (OTC-PINK: "HALB”) We hope you have had an opportunity to check out this Press release’s Part A. This Part B supplements that release of a few days ago. As always reach out to us if ...
Early Pilot Study Data from Veteran Volunteers is Compelling. Jackson Center, PA September 4, 2024 – Halberd Corporation (OTC-PINK: "HALB”) To our shareholders. As promised, this is the second of three Press Releases on our recent progress. If you have not had a chance to review that last one, on the good news on our ...
Walt Disney once said, “All our dreams can come true if we have the courage to pursue them”. Jackson Center, PA May 22, 2024 – Halberd Corporation (OTC-PINK: "HALB”) in cooperation with Athena GTX, Inc is standing at the threshold of some major advancements to treat the issues facing not only our military but people ...
Daniel J. Harvey and Adam Lambert Improving Servicemember Transition to Reduce Veteran Suicide Act, passed the U.S. House unanimously. Jackson Center, PA, May 9, 2024 – Halberd Corporation’s (OTC-PINK: "HALB”) two active programs for the treatment and mitigation of the negative effects of traumatic brain injury (TBI) align well with the newly passed bill in ...
LDN+ Drug Designed to Combat PTSD and Suicidal Ideation Jackson Center, PA, April 30, 2024 – Halberd Corporation (OTC-PINK: "HALB”) announced a pre-pilot study of its patented LDN+ drug with military volunteers has now begun with limited participants but is currently expected to accelerate rapidly pending successful initial results. This plan includes a wider pilot ...
Jackson Center, PA, April 4, 2024 – Halberd Corporation’s (OTC-PINK: "HALB”) Patented LDN+ Drug hits an enormous milestone as it enters a significant Safety Trial Protocol under a CRADA contract for Military Active Duty and Veterans. Halberd Corporation's patented drug, LDN+, a combination of low-dose Naltrexone and Cyclobenzaprine, is a central part of a just ...
MSU Research for Halberd to Transcend the TBI Nasal Spray Jackson Center, PA November 15, 2023 – Halberd Corporation (OTC-PINK: "HALB”) is in talks with Mississippi State University (MSU) to extend its original six-month research arrangement by an additional two years, encompassing yet-to-be defined projects. This decision stems from MSU's exceptional performance in the recent ...